Ocular Therapeutix added an experienced eye-care and drug-company leader, and another director plans to leave without a dispute. The share awards may add shares over time, but the filing reports no change to the company's business.
Dr. Sherif's experience in eye care and drug companies could help board discussions. The filing reports no dispute or change to company plans. His share awards may add shares over time, but the filing gives no total share count to show their scale.
Follow Ocular Therapeutix, Inc. (OCUL) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for OCUL